RxDoctor Payments Data

John Warren, OD

Optometrist · Mt Pleasant, WINPI 1609868124

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (52.2%), speaking fees and consulting fees — rather than concentrated in one kind of arrangement. 15 manufacturers reported payments, led by Lumenis BE Inc at 24.3% of the total. Among optometrist clinicians in WI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$6,619in general payments, 2019–2025

Across 25 payments — averaging $264.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lumenis BE Inc$2K
  • Optovue, Inc.$1K
  • Alcon$1K
  • Sight Sciences, Inc.$1K
  • Visionix USA, Inc$539
  • Coopervision Inc.$196
  • plus $809 from 9 others

What the payments were for

  • Consulting fees$1,05016%
  • Speaking & faculty fees$1,25019%
  • Travel & lodging$86113%
  • Food & beverage$3,45752%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,619 in reported general payments places this provider in the 95th percentile of 867 optometrist providers in Wisconsin.

See all optometrist providers in Wisconsin

Medicare billing

Part B allowed, 2024
$67,992
Medicare patients
314
Services billed
2,642

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Timolol Maleate38$5,334
Latanoprost146$1,528
Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha14$176

Paid to pharmacies, not to this prescriber.

Other optometrist in Mt Pleasant

See the full list for Wisconsin

Where these figures come from

Is this you, or does something look wrong? →